학술논문

Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase
Document Type
Article
Source
In: Antiviral Research. (Antiviral Research, October 2023, 218)
Subject
Language
English
ISSN
18729096
01663542